Name: Barinthus Biotherapeutics plc (BRNS) Balance Sheet
Creator: FinSpry

Barinthus Biotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Barinthus Biotherapeutics plc (BRNS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	110.66	142.09	194.39	214.05	43.27
Cash & Short-Term Investments	110.66	142.09	194.39	214.05	43.27
Accounts Receivable	13.00	13.34	5.85	0.02	3.53
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.08	1.47	0.61	0.80	1.08
Total Current Assets	125.74	156.91	213.04	226.77	47.90
Non-Current Assets
Property, Plant & Equipment (Net)	11.76	19.40	15.71	9.09	2.77
Goodwill	0.00	12.21	12.21	12.63	0.00
Intangible Assets	21.95	25.11	28.27	31.43	0.00
Other Non-Current Assets	0.88	0.88	0.98	6.23	0.00
Total Non-Current Assets	34.59	57.60	57.16	59.38	0.00
Total Assets	160.33	214.51	270.21	280.72	50.67
Current Liabilities
Accounts Payable	2.47	1.60	3.75	2.42	4.67
Short-Term Debt	1.92	0.00	0.00	0.16	0.00
Accrued Liabilities	9.53	6.80	6.14	7.88	2.54
Deferred Revenue	1.74	0.00	0.00	0.18	0.25
Other Current Liabilities	7.11	9.21	8.06	7.88	0.00
Total Current Liabilities	15.66	12.60	12.24	11.16	7.64
Non-Current Liabilities
Long-Term Debt	10.09	11.19	8.34	6.54	44.70
Deferred Tax Liabilities	0.44	0.57	3.75	8.08	0.00
Other Non-Current Liabilities	4.01	3.15	2.68	2.37	0.00
Total Non-Current Liabilities	14.54	14.91	14.76	17.00	0.00
Total Liabilities	30.19	27.51	27.00	28.15	53.81
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-237.66	-176.59	-103.24	-108.59	-57.72
Accumulated Other Comprehensive Income	-25.87	-23.32	-33.46	-8.49	-1.24
Additional Paid-in Capital	393.47	386.60	379.50	369.10	0.00
Minority Interest	0.11	0.21	0.31	0.44	0.00
Shares Outstanding	40.23	38.64	37.68	37.19	0.00
Total Stockholders' Equity	130.03	186.78	242.90	252.56	-3.15
Total Liabilities & Equity	160.33	214.51	270.21	280.72	0.00